Skip to main content

Cardiology Update London 2018

The Royal Society of Medicine, London, UK
Type of event
on site


Dear Colleagues

It is a real pleasure to announce the 2nd Postgraduate Course of the Royal Brompton and Harefield NHS Foundation Trust & Imperial College, the Cardiology Update London.

Cardiology and cardiovascular medicine in general, is a rapidly expanding field with impressive developments and innovations over the last years. For physicians, be it general practitioners, cardiologists or cardiac surgeons, it is therefore important to keep pace with a challenging environment. To that end, we have designed a postgraduate course, the Cardiology Update London, to summarize, at the end of the year, the most important new developments, innovations, but also failures that will all affect cardiovascular diagnosis and management in our everyday practice.

We have selected an international faculty of high standing experts both from the Trust and worldwide, covering the entire spectrum of cardiovascular medicine from prevention to intervention, from valvular heart disease to heart failure, and from conservative management to intervention and surgical operations. Thus, the course will give an up-to-date overview about current diagnosis and management of the most important cardiovascular conditions during two days in London.

We would be most happy to welcome you at the Royal Society of Medicine in central London to enjoy two days of interactive education for the benefit of your practice and your patients.

Yours sincerely,

Prof. Thomas F. Lüscher

Dr. Richard Grocott-Mason

Prof. Kim Fox

Dr. Ruth Amstein

In collaboration with





Under the Auspices of




Program Monday
Program Tuesday


Monday, December 17th, 2018

Venue: Royal Society of Medicine, London

08:30 - 08:45 | Welcome Address
08.30 The Royal Brompton & Harefield Hospital Trust K. Fox and T.F. Lüscher


08:45 - 10:15 | Opening Lectures: From the Past to the Future
Chairs: K. Fox and R. Grocott-Mason, London
08:45 Clonal Hematopoiesis: A potent newly recognized cardiovascular risk factor P. Libby, Boston
09:15 Tailor-made decision making on surgical or percutaneous revascularisation based on non-invasive imaging and comorbidities P. Serruys, Rotterdam
09:45 Heart failure 10 years from now: What are the expectations? M. Packer, Dallas
10:15-10:45 COFFEE BREAK  


10:45 - 13:00 | Session 1: Risk Factors and Prevention
Chairs: J.J. Bax, P. Libby and J.M. Shah
10:45 Hypertension: the new ESC Guidelines M.D. Lobo, London
11:05 Device-based therapies for hypertension F. Mahfoud, Homburg, Saar
11:25 The ESC Guidelines on lipid management: What is valid and what needs to be changed? U. Landmesser, Berlin
11:45 PCSK9 inhibition: from genetics to therapeutics P.G. Steg, Paris
12:05 Diabetes and cardiovascular disease N. Poulter, London
12:25 Discussion  
13:00-14:00 LUNCH BUFFET  


14:00 - 16:00 | Session 2: Angina and ACS / Cardio-Oncology
Chairs: U. Landmesser and K. Mohan
14:00 Cancer patients and HF A. Lyon, London
14:20 The best imaging modalities to diagnose CAD J.J. Bax, Leiden
14:40 PCI versus CABG in Stable CAD: Patient selection based on evidence B. Gersh, Rochester
15:00 DAPT or anticoagulation: ESC Guidelines and the new field of thrombocardiology P.G. Steg, Paris
15:20 Non-obstructive CAD, MINOCA A. Lerman, Rochester
15:40 Discussion  
16:00-16:30 COFFEE BREAK  


16:30 - 18:00 | Session 3: Arrhythmias
Chairs: B. Gersh, S. Haldar and A.G. Ballani
16:30 What is new in AF management? Antiarrhythmic drugs and NOACs A.J. Camm, London
16:50 Atrial fibrillation ablation: expanding indications S. Ernst, London
17:10 Towards precision medicine in the prevention of genetically-mediated sudden death J. Brugada, Barcelona
17:30 Diagnosis and management of syncopies: the new ESC Guidelines M. Brignole, Lavagna
17:50 Discussion  


Tuesday, December 18th, 2018

Venue: Royal Society of Medicine, London

08:30 - 10:30 | Session 4: Valvular Heart Disease / ACS
Chairs: T.F. Lüscher and S. Windecker
08.30 The role of imaging in valve disease J.J. Bax, Leiden
08.50 TAVI: current indications and future developments B. Prendergast, London
09.10 An interesting patient with aortic stenosis O. Samara, London
09:25 Mitral valve repair: surgery or intervention? G. Nickenig, Bonn
09:45 Management of ACS today, including ESC Guidelines on myocardial revascularisation S. Windecker, Berne
10:10 Discussion  
10:30-11:00 COFFEE BREAK  


11:00 - 12:15 | Session 5: Heart Failure - Classification, Assessment and Treatment
Chairs: M. Packer, M. Pfeffer and B.K. Mishra
11.00 Classification of heart failure according to the ESC Guidelines J. Cleland, Glasgow
11.20 A clinical case of heart failure H.O. Savage, Basildon
11.35 Treatment of heart failure: Drugs and devices M. Cowie, London
12:00 Discussion  
12:15-13:15 LUNCH BUFFET  


13:15 - 14:45 | Session 6: Heart Failure and Comorbidities
Chairs: M. Cowie and A. Maisel
13.15 Diabetes and HF M. Packer, Dallas
13.40 Atrial fibrillation and HF: an evil conspiracy J. Cleland, Glasgow
14.05 Pharmacological management of HFrEF M. Pfeffer, Boston
14:30 Discussion  
14.45-15:15 COFFEE BREAK  


15:15 - 16:30 | Session 7: Cardiomyopathies/Heart Failure
Chairs: J. Cleland and P. Kalra
15.15 The role of biomarkers in heart failure A. Maisel, San Diego/Basel
15.35 Sudden cardiac death in HCM: Pathophysiology, risk stratification and management B. Gersh, Rochester
15.55 Hereditary cardiomyopathies and HF S. Prasad, London
16:15 Discussion  


16:30 - 17:00 | The Paul Hamilton Wood Lecture
Chairs: K. Fox and T.F. Lüscher
16:30 Ventricular remodeling: a personal jouney M. Pfeffer, Boston
17:00 Wrap-up and Close T. F. Lüscher, London


Anil G. Ballani
Mumbai, IND

Jeroen J. Bax
Leiden, NL

Michele Brignole
Lavagna, IT

Josep Brugada
Barcelona, ES

A. John Camm
London, GB

John Cleland
Glasgow, GB

Martin Cowie
London, GB

Sabine Ernst
London, GB

Kim Fox
London, GB

Bernard Gersh
Rochester MN, US

Richard Grocott-Mason
London, GB

Shouvik Haldar
London, GB

Jay M. Shah
Ahmedabad, IND

Paul Kalra
Havant, GB

Ulf Landmesser
Berlin, DE

Amir Lerman
Rochester MN, US

Peter Libby
Boston, US

Melvin D. Lobo
London, GB

Thomas F. Lüscher
London, GB/Zurich, CH

Alexander Lyon
London, GB

Felix Mahfoud
Homburg Saar, DE

Alan Maisel
San Diego, US/Basel, CH

Bijay K. Mishra
Bhubaneshwar, IND

Krishnamurthy Mohan
Chennai, IND

Georg Nickenig
Bonn, DE

Milton Packer
Dallas, US

Marc Pfeffer
Boston, US

Neil Poulter
London, GB

Sanjay Prasad
London, GB

Bernard Prendergast
London, GB

Osama Samara
London, GB

Henry Oluwasefunmi Savage
Basildon, GB

Patrick Serruys
Rotterdam, NL

P. Gabriel Steg
Paris, FR

Stephan Windecker
Berne, CH



Category Price
Registration fees  
Regular fee GBP 300
Early registration fee (before November 24, 2018) GBP 250
Trainees/Residents, Research fellows, Nurses, Students <35 years (ID proof required)  
Regular fee GBP 150
Early registration fee (before November 24, 2017) GBP 100
Day ticket GBP 150

Register online. Deadline for registration: 12 December 2018

For group registrations a minimum number of 10 participants is required. Please contact Nadine-Estelle Kaltheuner to obtain further information.

Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

Modification & Cancellation

All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Zurich Heart House. For each modification requested by the participant, GBP 50 will be charged for administrative costs. In case of cancellation up to 1st November 2018, deposits will be refunded less 35% for administrative costs. After this date, no refund will be possible.


Zurich Heart House, Foundation for Cardiovascular Research
Dr. Ruth Amstein
Nadine-Estelle Kaltheuner
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90


The Royal Society of Medicine
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom


The Cardiology Update London has been approved by:

Federation of the Royal Colleges of Physicians of the United Kingdom for CPD credits
14 category 1 (external) CPD credits

European Accreditation Council for Continuing Medical Education (EACCME)
13 European CME credits (ECMECs)


Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Recommended by the British Cardiovascular Society